Honeysuckle therapy improves clinical management of EGFR inhibitor-related skin rash in patients
Honeysuckle Therapy May Help Manage Skin Rashes from EGFR Inhibitors
This meta-analysis of 534 patients evaluated honeysuckle therapy for managing EGFR inhibitor-related skin rash. The analysis found that hone…
Honeysuckle therapy may delay the onset and reduce the severity of skin rashes caused by certain cancer treatments like EGFR inhibitors.
EGFR inhibitors show reproducible activity and manageable toxicity in locally advanced or metastatic anal squamous cell carcinoma
EGFR Inhibitors Show Activity in Advanced Anal Squamous Cell Carcinoma
This meta-analysis of 404 patients evaluated EGFR inhibitors (cetuximab and panitumumab) for anal squamous cell carcinoma. The analysis foun…
New analysis shows that EGFR inhibitors like cetuximab and panitumumab may improve response rates for patients with advanced anal squamous c…
Narrative review examines driver mutations and immunotherapy response in non-small cell lung cancer
Does your lung cancer's genetic makeup change how well immune therapy works?
This narrative review explores how targetable driver gene alterations in non-small cell lung cancer (NSCLC) influence the tumor immune micro…
Lung cancer's genetic drivers actively reshape the tumor's immune environment, causing immunotherapy to work differently depending on a pati…